Skip to main content
. 2015 Apr 19;2015:187849. doi: 10.1155/2015/187849

Table 5.

Effects of PMA activation, in vitro vitamin C, and DHA diet supplementation on inflammatory gene expression.

Control PMA PMA + VitC ANOVA
S A S × A
Gene expression
 COX2 Placebo 1.00 ± 0.12 4.37 ± 1.65# 1.21 ± 0.31$ X
Experimental 1.14 ± 0.25 2.32 ± 0.81 1.54 ± 0.33
 NFκβ Placebo 1.0 ± 0.14a 1.91 ± 0.34b 0.88 ± 0.09a X X X
Experimental 0.90 ± 0.08a 0.98 ± 0.14a 0.84 ± 0.06a
 IL8 Placebo 1.00 ± 0.15ª 3.19 ± 1.19b 1.01 ± 0.36a    X
Experimental 0.89 ± 0.13a 0.89 ± 0.12a 1.09 ± 0.18a
 TNFα Placebo 1.00 ± 0.12 2.30 ± 0.51# 0.99 ± 0.14 X
Experimental 1.03 ± 0.15 1.24 ± 0.26 0.97 ± 0.12$
 MPO Placebo 1.00 ± 0.16 1.32 ± 0.27 1.73 ± 0.59 X X
Experimental 2.09 ± 0.61 1.86 ± 0.66 4.72 ± 1.23#$

Statistical analysis: two-way ANOVA, p < 0.05. S: supplementation effect; A: activation effect; S × A: interaction between supplementation and activation effects. X indicates significant effect of the statistical factor S, A, or S × A. #Difference with respect to the control group; $differences between PMA and PMA + VitC group. When interaction S × A exists between supplementation and activation factors, different letters reveal significant differences. Results are the mean ± SEM.